Use of blood outgrowth endothelial cells for gene therapy for hemophilia A

Blood

Volumn 99, Issue 2, 2002, Pages 457-462

  Lin, Yi ^a,b   Chang, Liming ^a,b   Solovey, Anna ^a,b   Healey, John F ^a,b   Lollar, Pete ^a,b   Hebbel, Robert P ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COMPLEMENTARY DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OUTGROWTH ENDOTHELIUM CELL; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; CRYOPRESERVATION; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC TRANSFECTION; HEMOPHILIA A; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERIPHERAL CIRCULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REFERENCE VALUE; SCID MOUSE; SPLEEN CELL;

EID: 0037079740     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.457     Document Type: Article

References (29)

1. Hemophilia A
2. Gene therapy for hemophilias
3. The functional domains of coagulation factor VIII:C
4. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule
5. A large region (95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity
6. Novel forms of B-domain - Deleted recombinant factor VIII molecules: Construction and biochemical characterization
7. Gene therapy for hemophilia
8. Animal testing of retroviral-mediated gene therapy for factor VIII deficiency
9. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A
10. Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: Applicability to haemophilia A gene therapy
11. Sustained expression of human factor VIII in mice using a parvovirus-based vector
12. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver
13. High-level tissue-specific expression of functional human factor VIII in mice
14. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice
15. Sequences in the coding region of clotting factor VIII act as dominant inhibitors of RNA accumulation and protein production
16. Origins of circulating endothelial cells and endothelial outgrowth from blood
17. Antigenicity of putative phospholipid membrane-binding residues in factor VIII
18. Structure of human factor VIII
19. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
20. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII
21. The clinical and laboratory diagnosis of hemorrhagic disorders
22. A novel technique for culture of human dermal microvascular endothelial cells under either serum-free or serum-supplemented conditions: Isolation by panning and stimulation with vascular endothelial growth factor
23. The nonobese diabetic scid mouse: Model for spontaneous thymomagenesis associated with immunodeficiency
24. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice
25. Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice
26. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice
27. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A
28. Implantation of autologous skin fibroblast genetically modified to secret clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients